Catch up on the latest news about what we’ve been up to and what’s happening at Haapaniemi Lab, including new job openings, research updates, new publications and team events.
The Norwegian Cancer Society has granted our lab NOK 7 970 000 for developing CRISPR-Cas gene therapy for blood cancer predisposition syndromes for 2022-2025. The
Zhuokun Li won the Best Poster Award at the annual CRISPR meeting at the Wellcome Trust Sanger Institute.
We attended the 2021 Cold Spring Harbor meeting on Genome Engineering: CRISPR Frontiers. The goal for the conference was to “foster fruitful and creative interactions
Oslo Science Park News interviewed our group leader Emma about how she first got into science, what it’s like working at NCMM and her thoughts about CRISPR technology.